EXCLUSIVE LICENSE AGREEMENT WITH SHANDONG KEXING BIOPRODUCTS CO., LTD IN RELATION TO CMAB008Exclusive License Agreement • June 29th, 2021
Contract Type FiledJune 29th, 2021This announcement is made by Mabpharm Limited (the “Company”, together with its subsidiaries, the “Group”), on a voluntary basis to inform the shareholders and potential investors of the Company about the latest business updates of the Group.